| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |